ASNM's activities focus on innovative cutting-edge research in nanomedicine as well as the applications of nanotechnology to the pharmaceutical and biotechnology industries. While promoting seminal research activities in nanomedicine worldwide, issues such as ethics, safety and toxicity, intellectual property, and commercialization will also be addressed and explored.
The American Chemistry Council's Nanotechnology Panel is composed of companies engaged in the production, distribution, and/or use of chemicals with business interests in the products and applications of nanotechnology. The Panel is actively involved in advocating the use of information and the completion of research on nanomaterials that facilitate understanding and manage the health and environmental issues associated with nanoscale materials.
The overarching goals of the group are: to facilitate the exchange of ideas and knowledge among practitioners, researchers, scholars, teachers, and others interested in risk analysis and emerging nanoscale materials; to encourage collaborative research on risk analysis and emerging nanoscale materials; and to provide leadership and play an active role in advancing issues related to risk analysis and emerging nanoscale materials.
The Virginia Nanotechnology Initiative (VNI) is a statewide consortium of Virginia's universities, federal labs, state agencies, and industrial partners, dedicated to promoting collaborative nanotechnology research, workforce development, technology transfer and commercialization.